Effect of beraprost sodium on renal function and p38MAPK signaling pathway in rats with diabetic nephropathy

Effect of beraprost sodium on renal function and p38MAPK signaling pathway in rats with diabetic nephropathy

Purpose: To investigate the effect of beraprost sodium (BPS) on renal function and P38MAPK pathway in diabetic nephropathy (DN) rats.Methods: Sprague Dawley (SD) rats (n = 30) were randomly divided into three groups, viz, normal control (NC), diabetic nephropathy (DN) and beraprost sodium (BPS). Cre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Tropical journal of pharmaceutical research 2022-06, Vol.21 (5), p.939-942
Hauptverfasser: Xie, Liangxiao, Dong, Jiajia, Wu, Jinzhi, Wei, Changshun, Xu, Kezhen, Lai, Pengbin, Zha, Xiaoyun
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 942
container_issue 5
container_start_page 939
container_title Tropical journal of pharmaceutical research
container_volume 21
creator Xie, Liangxiao
Dong, Jiajia
Wu, Jinzhi
Wei, Changshun
Xu, Kezhen
Lai, Pengbin
Zha, Xiaoyun
description Purpose: To investigate the effect of beraprost sodium (BPS) on renal function and P38MAPK pathway in diabetic nephropathy (DN) rats.Methods: Sprague Dawley (SD) rats (n = 30) were randomly divided into three groups, viz, normal control (NC), diabetic nephropathy (DN) and beraprost sodium (BPS). Creatinine (Cr), blood urea nitrogen (BUN) and fasting blood glucose (FBG), were determined by Hitachi 7020 automatic biochemical analyzer, while low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG) and total cholesterol (TC) were measured by Olympus 400 automatic biochemical analyzer. Western blot analysis was performed to examine protein expression. Interleukin-6 (IL-6), hs-CRP, and TNF-α levels were evaluated using enzyme linked immunosorbent assay (ELISA).Results: After 8 weeks of treatment, renal function indices (urine output, KW/BW, UAlb/24 h, Cr and BUN), blood lipid indices (FBG, LDL-C, TG and TC) and inflammatory factors levels (IL-6, hs-CRP and TNF-α) in DN group were higher than NC group (p < 0.05). In BPS group, renal function and blood lipid indices and inflammatory factor levels decreased when compared to DN group (p < 0.05). Furthermore, BPS inhibited the protein expression of p-P38MAPK, TGF-β1 and COX-2.Conclusion: Beraprost sodium improves renal function in DN rats by inhibiting P38MAPK signalingpathway.
doi_str_mv 10.4314/tjpr.v21i5.5
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_4314_tjpr_v21i5_5</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_4314_tjpr_v21i5_5</sourcerecordid><originalsourceid>FETCH-LOGICAL-c107t-3cda27b4330863a272e50ec774d3ee6fff87ae73c7debaf3d7eccfa15fae3e0a3</originalsourceid><addsrcrecordid>eNotkM1OwzAQhC0EEqVw4wH8ACTYcRwnx6oqP6IIDnCONva6cZUmke1S9e1Joaed1YxGmo-Qe87SXPD8MW5Hn_5k3MlUXpAZl1WRVGWmLs9aVlVxTW5C2DImi6riM9KtrEUd6WBpgx5GP4RIw2DcfkeHnnrsoaN23-vophd6Q0dRvi8-32hwm8lz_YaOENsDHKmb8hADPbjYUuOgweg07XFs_XDKHG_JlYUu4N35zsn30-pr-ZKsP55fl4t1ojlTMRHaQKaaXAhWFmKSGUqGWqncCMTCWlsqQCW0MtiAFUah1ha4tIACGYg5efjv1dOc4NHWo3c78Meas_pEqj6Rqv9I1VL8ApVdYPQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Effect of beraprost sodium on renal function and p38MAPK signaling pathway in rats with diabetic nephropathy</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>African Journals Online (Open Access)</source><source>Bioline International</source><source>Free Full-Text Journals in Chemistry</source><creator>Xie, Liangxiao ; Dong, Jiajia ; Wu, Jinzhi ; Wei, Changshun ; Xu, Kezhen ; Lai, Pengbin ; Zha, Xiaoyun</creator><creatorcontrib>Xie, Liangxiao ; Dong, Jiajia ; Wu, Jinzhi ; Wei, Changshun ; Xu, Kezhen ; Lai, Pengbin ; Zha, Xiaoyun</creatorcontrib><description>Purpose: To investigate the effect of beraprost sodium (BPS) on renal function and P38MAPK pathway in diabetic nephropathy (DN) rats.Methods: Sprague Dawley (SD) rats (n = 30) were randomly divided into three groups, viz, normal control (NC), diabetic nephropathy (DN) and beraprost sodium (BPS). Creatinine (Cr), blood urea nitrogen (BUN) and fasting blood glucose (FBG), were determined by Hitachi 7020 automatic biochemical analyzer, while low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG) and total cholesterol (TC) were measured by Olympus 400 automatic biochemical analyzer. Western blot analysis was performed to examine protein expression. Interleukin-6 (IL-6), hs-CRP, and TNF-α levels were evaluated using enzyme linked immunosorbent assay (ELISA).Results: After 8 weeks of treatment, renal function indices (urine output, KW/BW, UAlb/24 h, Cr and BUN), blood lipid indices (FBG, LDL-C, TG and TC) and inflammatory factors levels (IL-6, hs-CRP and TNF-α) in DN group were higher than NC group (p &lt; 0.05). In BPS group, renal function and blood lipid indices and inflammatory factor levels decreased when compared to DN group (p &lt; 0.05). Furthermore, BPS inhibited the protein expression of p-P38MAPK, TGF-β1 and COX-2.Conclusion: Beraprost sodium improves renal function in DN rats by inhibiting P38MAPK signalingpathway.</description><identifier>ISSN: 1596-5996</identifier><identifier>EISSN: 1596-9827</identifier><identifier>DOI: 10.4314/tjpr.v21i5.5</identifier><language>eng</language><ispartof>Tropical journal of pharmaceutical research, 2022-06, Vol.21 (5), p.939-942</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Xie, Liangxiao</creatorcontrib><creatorcontrib>Dong, Jiajia</creatorcontrib><creatorcontrib>Wu, Jinzhi</creatorcontrib><creatorcontrib>Wei, Changshun</creatorcontrib><creatorcontrib>Xu, Kezhen</creatorcontrib><creatorcontrib>Lai, Pengbin</creatorcontrib><creatorcontrib>Zha, Xiaoyun</creatorcontrib><title>Effect of beraprost sodium on renal function and p38MAPK signaling pathway in rats with diabetic nephropathy</title><title>Tropical journal of pharmaceutical research</title><description>Purpose: To investigate the effect of beraprost sodium (BPS) on renal function and P38MAPK pathway in diabetic nephropathy (DN) rats.Methods: Sprague Dawley (SD) rats (n = 30) were randomly divided into three groups, viz, normal control (NC), diabetic nephropathy (DN) and beraprost sodium (BPS). Creatinine (Cr), blood urea nitrogen (BUN) and fasting blood glucose (FBG), were determined by Hitachi 7020 automatic biochemical analyzer, while low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG) and total cholesterol (TC) were measured by Olympus 400 automatic biochemical analyzer. Western blot analysis was performed to examine protein expression. Interleukin-6 (IL-6), hs-CRP, and TNF-α levels were evaluated using enzyme linked immunosorbent assay (ELISA).Results: After 8 weeks of treatment, renal function indices (urine output, KW/BW, UAlb/24 h, Cr and BUN), blood lipid indices (FBG, LDL-C, TG and TC) and inflammatory factors levels (IL-6, hs-CRP and TNF-α) in DN group were higher than NC group (p &lt; 0.05). In BPS group, renal function and blood lipid indices and inflammatory factor levels decreased when compared to DN group (p &lt; 0.05). Furthermore, BPS inhibited the protein expression of p-P38MAPK, TGF-β1 and COX-2.Conclusion: Beraprost sodium improves renal function in DN rats by inhibiting P38MAPK signalingpathway.</description><issn>1596-5996</issn><issn>1596-9827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNotkM1OwzAQhC0EEqVw4wH8ACTYcRwnx6oqP6IIDnCONva6cZUmke1S9e1Joaed1YxGmo-Qe87SXPD8MW5Hn_5k3MlUXpAZl1WRVGWmLs9aVlVxTW5C2DImi6riM9KtrEUd6WBpgx5GP4RIw2DcfkeHnnrsoaN23-vophd6Q0dRvi8-32hwm8lz_YaOENsDHKmb8hADPbjYUuOgweg07XFs_XDKHG_JlYUu4N35zsn30-pr-ZKsP55fl4t1ojlTMRHaQKaaXAhWFmKSGUqGWqncCMTCWlsqQCW0MtiAFUah1ha4tIACGYg5efjv1dOc4NHWo3c78Meas_pEqj6Rqv9I1VL8ApVdYPQ</recordid><startdate>20220616</startdate><enddate>20220616</enddate><creator>Xie, Liangxiao</creator><creator>Dong, Jiajia</creator><creator>Wu, Jinzhi</creator><creator>Wei, Changshun</creator><creator>Xu, Kezhen</creator><creator>Lai, Pengbin</creator><creator>Zha, Xiaoyun</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20220616</creationdate><title>Effect of beraprost sodium on renal function and p38MAPK signaling pathway in rats with diabetic nephropathy</title><author>Xie, Liangxiao ; Dong, Jiajia ; Wu, Jinzhi ; Wei, Changshun ; Xu, Kezhen ; Lai, Pengbin ; Zha, Xiaoyun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c107t-3cda27b4330863a272e50ec774d3ee6fff87ae73c7debaf3d7eccfa15fae3e0a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xie, Liangxiao</creatorcontrib><creatorcontrib>Dong, Jiajia</creatorcontrib><creatorcontrib>Wu, Jinzhi</creatorcontrib><creatorcontrib>Wei, Changshun</creatorcontrib><creatorcontrib>Xu, Kezhen</creatorcontrib><creatorcontrib>Lai, Pengbin</creatorcontrib><creatorcontrib>Zha, Xiaoyun</creatorcontrib><collection>CrossRef</collection><jtitle>Tropical journal of pharmaceutical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xie, Liangxiao</au><au>Dong, Jiajia</au><au>Wu, Jinzhi</au><au>Wei, Changshun</au><au>Xu, Kezhen</au><au>Lai, Pengbin</au><au>Zha, Xiaoyun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of beraprost sodium on renal function and p38MAPK signaling pathway in rats with diabetic nephropathy</atitle><jtitle>Tropical journal of pharmaceutical research</jtitle><date>2022-06-16</date><risdate>2022</risdate><volume>21</volume><issue>5</issue><spage>939</spage><epage>942</epage><pages>939-942</pages><issn>1596-5996</issn><eissn>1596-9827</eissn><abstract>Purpose: To investigate the effect of beraprost sodium (BPS) on renal function and P38MAPK pathway in diabetic nephropathy (DN) rats.Methods: Sprague Dawley (SD) rats (n = 30) were randomly divided into three groups, viz, normal control (NC), diabetic nephropathy (DN) and beraprost sodium (BPS). Creatinine (Cr), blood urea nitrogen (BUN) and fasting blood glucose (FBG), were determined by Hitachi 7020 automatic biochemical analyzer, while low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG) and total cholesterol (TC) were measured by Olympus 400 automatic biochemical analyzer. Western blot analysis was performed to examine protein expression. Interleukin-6 (IL-6), hs-CRP, and TNF-α levels were evaluated using enzyme linked immunosorbent assay (ELISA).Results: After 8 weeks of treatment, renal function indices (urine output, KW/BW, UAlb/24 h, Cr and BUN), blood lipid indices (FBG, LDL-C, TG and TC) and inflammatory factors levels (IL-6, hs-CRP and TNF-α) in DN group were higher than NC group (p &lt; 0.05). In BPS group, renal function and blood lipid indices and inflammatory factor levels decreased when compared to DN group (p &lt; 0.05). Furthermore, BPS inhibited the protein expression of p-P38MAPK, TGF-β1 and COX-2.Conclusion: Beraprost sodium improves renal function in DN rats by inhibiting P38MAPK signalingpathway.</abstract><doi>10.4314/tjpr.v21i5.5</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1596-5996
ispartof Tropical journal of pharmaceutical research, 2022-06, Vol.21 (5), p.939-942
issn 1596-5996
1596-9827
language eng
recordid cdi_crossref_primary_10_4314_tjpr_v21i5_5
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; African Journals Online (Open Access); Bioline International; Free Full-Text Journals in Chemistry
title Effect of beraprost sodium on renal function and p38MAPK signaling pathway in rats with diabetic nephropathy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T23%3A31%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20beraprost%20sodium%20on%20renal%20function%20and%20p38MAPK%20signaling%20pathway%20in%20rats%20with%20diabetic%20nephropathy&rft.jtitle=Tropical%20journal%20of%20pharmaceutical%20research&rft.au=Xie,%20Liangxiao&rft.date=2022-06-16&rft.volume=21&rft.issue=5&rft.spage=939&rft.epage=942&rft.pages=939-942&rft.issn=1596-5996&rft.eissn=1596-9827&rft_id=info:doi/10.4314/tjpr.v21i5.5&rft_dat=%3Ccrossref%3E10_4314_tjpr_v21i5_5%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true